|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
(+ 0 more)
153 a.a.
|
 |
|
|
|
|
|
|
|
(+ 0 more)
88 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Crystal structure of the complex of caspase-8 with the tripe ketone inhibitor zevd-dcbmk
|
|
Structure:
|
 |
Caspase-8 alpha-chain. Chain: a, c, e, g, i, k. Engineered: yes. Caspase-8 beta-chain. Chain: b, d, f, h, j, l. Engineered: yes. Phq-glu-val-asp-dichloromethylketone inhibitor. Chain: t, u, v, w, x, y. Synonym: z-evd-dcbmk.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Other_details: the peptide was chemically synthesized.
|
|
Biol. unit:
|
 |
Hexamer (from
)
|
|
Resolution:
|
 |
|
2.80Å
|
R-factor:
|
0.230
|
R-free:
|
0.302
|
|
|
Authors:
|
 |
H.Blanchard,M.G.Grutter
|
Key ref:
|
 |
H.Blanchard
et al.
(1999).
The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis.
Structure,
7,
1125-1133.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
10-Jul-99
|
Release date:
|
10-Jul-00
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B, C, D, E, F, G, H, I, J, K, L:
E.C.3.4.22.61
- Caspase-8.
|
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
apoptosis
|
2 terms
|
 |
|
Biochemical function
|
cysteine-type peptidase activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
7:1125-1133
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis.
|
|
H.Blanchard,
L.Kodandapani,
P.R.Mittl,
S.D.Marco,
J.F.Krebs,
J.C.Wu,
K.J.Tomaselli,
M.G.Grütter.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: In the initial stages of Fas-mediated apoptosis the cysteine
protease caspase-8 is recruited to the cell receptor as a zymogen (procaspase-8)
and is incorporated into the death-signalling complex. Procaspase-8 is
subsequently activated leading to a cascade of proteolytic events, one of them
being the activation of caspase-3, and ultimately resulting in cell destruction.
Variations in the substrate specificity of different caspases have been
reported. RESULTS: We report here the crystal structure of a complex of the
activated human caspase-8 (proteolytic domain) with the irreversible peptidic
inhibitor Z-Glu-Val-Asp-dichloromethylketone at 2.8 A resolution. This is the
first structure of a representative of the long prodomain initiator caspases and
of the group III substrate specificity class. The overall protein architecture
resembles the caspase-1 and caspase-3 folds, but shows distinct structural
differences in regions forming the active site. In particular, differences
observed in subsites S(3), S(4) and the loops involved in inhibitor interactions
explain the preference of caspase-8 for substrates with the sequence
(Leu/Val)-Glu-X-Asp. CONCLUSIONS: The structural differences could be correlated
with the observed substrate specificities of caspase-1, caspase-3 and caspase-8,
as determined from kinetic experiments. This information will help us to
understand the role of the various caspases in the propagation of the apoptotic
signal. The information gained from this investigation should be useful for the
design of specific inhibitors.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 1.
Figure 1. Ribbon diagram of the (p18-p12)[2] dimer
structure. The p18 and p12 chains are coloured red and green,
respectively. The loops around the active site are coloured dark
blue and labelled. The inhibitor (Z-EVD), which is covalently
bound to the active-site cysteine Cys285, is depicted as a
yellow ball-and-stick model. The twofold NCS axis relating the
two p18-p12 units is perpendicular to the plane of the paper.
(The figure was generated using the program MOLSCRIPT [40].)
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure
(1999,
7,
1125-1133)
copyright 1999.
|
|
| |
Figure was
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
N.Keller,
M.G.Grütter,
and
O.Zerbe
(2010).
Studies of the molecular mechanism of caspase-8 activation by solution NMR.
|
| |
Cell Death Differ, 17,
710-718.
|
 |
|
|
|
|
 |
V.Heussler,
A.Rennenberg,
and
R.Stanway
(2010).
Host cell death induced by the egress of intracellular Plasmodium parasites.
|
| |
Apoptosis, 15,
376-385.
|
 |
|
|
|
|
 |
J.W.Yu,
P.D.Jeffrey,
and
Y.Shi
(2009).
Mechanism of procaspase-8 activation by c-FLIPL.
|
| |
Proc Natl Acad Sci U S A, 106,
8169-8174.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Keller,
J.Mares,
O.Zerbe,
and
M.G.Grütter
(2009).
Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation.
|
| |
Structure, 17,
438-448.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.H.Jia,
J.Parodo,
A.Kapus,
O.D.Rotstein,
and
J.C.Marshall
(2008).
Dynamic regulation of neutrophil survival through tyrosine phosphorylation or dephosphorylation of caspase-8.
|
| |
J Biol Chem, 283,
5402-5413.
|
 |
|
|
|
|
 |
J.Dobó,
R.Swanson,
G.S.Salvesen,
S.T.Olson,
and
P.G.Gettins
(2006).
Cytokine response modifier a inhibition of initiator caspases results in covalent complex formation and dissociation of the caspase tetramer.
|
| |
J Biol Chem, 281,
38781-38790.
|
 |
|
|
|
|
 |
S.Cursi,
A.Rufini,
V.Stagni,
I.Condò,
V.Matafora,
A.Bachi,
A.P.Bonifazi,
L.Coppola,
G.Superti-Furga,
R.Testi,
and
D.Barilà
(2006).
Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression.
|
| |
EMBO J, 25,
1895-1905.
|
 |
|
|
|
|
 |
S.Misaghi,
G.A.Korbel,
B.Kessler,
E.Spooner,
and
H.L.Ploegh
(2006).
z-VAD-fmk inhibits peptide:N-glycanase and may result in ER stress.
|
| |
Cell Death Differ, 13,
163-165.
|
 |
|
|
|
|
 |
I.N.Lavrik,
A.Golks,
and
P.H.Krammer
(2005).
Caspases: pharmacological manipulation of cell death.
|
| |
J Clin Invest, 115,
2665-2672.
|
 |
|
|
|
|
 |
N.Yan,
and
Y.Shi
(2005).
Mechanisms of apoptosis through structural biology.
|
| |
Annu Rev Cell Dev Biol, 21,
35-56.
|
 |
|
|
|
|
 |
S.Piana,
Z.Taylor,
and
U.Rothlisberger
(2005).
Folding pathways for initiator and effector procaspases from computer simulations.
|
| |
Proteins, 59,
765-772.
|
 |
|
|
|
|
 |
S.J.Riedl,
and
Y.Shi
(2004).
Molecular mechanisms of caspase regulation during apoptosis.
|
| |
Nat Rev Mol Cell Biol, 5,
897-907.
|
 |
|
|
|
|
 |
X.Jiang,
and
X.Wang
(2004).
Cytochrome C-mediated apoptosis.
|
| |
Annu Rev Biochem, 73,
87.
|
 |
|
|
|
|
 |
A.Schweizer,
C.Briand,
and
M.G.Grutter
(2003).
Crystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathway.
|
| |
J Biol Chem, 278,
42441-42447.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.S.Kim,
J.W.Lee,
Y.H.Soung,
W.S.Park,
S.Y.Kim,
J.H.Lee,
J.Y.Park,
Y.G.Cho,
C.J.Kim,
S.W.Jeong,
S.W.Nam,
S.H.Kim,
J.Y.Lee,
N.J.Yoo,
and
S.H.Lee
(2003).
Inactivating mutations of caspase-8 gene in colorectal carcinomas.
|
| |
Gastroenterology, 125,
708-715.
|
 |
|
|
|
|
 |
K.M.Boatright,
M.Renatus,
F.L.Scott,
S.Sperandio,
H.Shin,
I.M.Pedersen,
J.E.Ricci,
W.A.Edris,
D.P.Sutherlin,
D.R.Green,
and
G.S.Salvesen
(2003).
A unified model for apical caspase activation.
|
| |
Mol Cell, 11,
529-541.
|
 |
|
|
|
|
 |
M.Bando,
M.Hasegawa,
Y.Tsuboi,
Y.Miyake,
M.Shiina,
M.Ito,
H.Handa,
K.Nagai,
and
T.Kataoka
(2003).
The mycotoxin penicillic acid inhibits Fas ligand-induced apoptosis by blocking self-processing of caspase-8 in death-inducing signaling complex.
|
| |
J Biol Chem, 278,
5786-5793.
|
 |
|
|
|
|
 |
S.Stoven,
N.Silverman,
A.Junell,
M.Hedengren-Olcott,
D.Erturk,
Y.Engstrom,
T.Maniatis,
and
D.Hultmark
(2003).
Caspase-mediated processing of the Drosophila NF-kappaB factor Relish.
|
| |
Proc Natl Acad Sci U S A, 100,
5991-5996.
|
 |
|
|
|
|
 |
A.Benchoua,
C.Couriaud,
C.Guégan,
L.Tartier,
P.Couvert,
G.Friocourt,
J.Chelly,
J.Ménissier-de Murcia,
and
B.Onténiente
(2002).
Active caspase-8 translocates into the nucleus of apoptotic cells to inactivate poly(ADP-ribose) polymerase-2.
|
| |
J Biol Chem, 277,
34217-34222.
|
 |
|
|
|
|
 |
A.Ueki,
Y.Isozaki,
A.Tomokuni,
T.Hatayama,
H.Ueki,
M.Kusaka,
M.Shiwa,
H.Arikuni,
T.Takeshita,
and
K.Morimoto
(2002).
Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals.
|
| |
Clin Exp Immunol, 129,
556-561.
|
 |
|
|
|
|
 |
O.Micheau,
M.Thome,
P.Schneider,
N.Holler,
J.Tschopp,
D.W.Nicholson,
C.Briand,
and
M.G.Grütter
(2002).
The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex.
|
| |
J Biol Chem, 277,
45162-45171.
|
 |
|
|
|
|
 |
Y.Shi
(2002).
Mechanisms of caspase activation and inhibition during apoptosis.
|
| |
Mol Cell, 9,
459-470.
|
 |
|
|
|
|
 |
J.C.Reed
(2001).
Apoptosis-regulating proteins as targets for drug discovery.
|
| |
Trends Mol Med, 7,
314-319.
|
 |
|
|
|
|
 |
J.Chai,
E.Shiozaki,
S.M.Srinivasula,
Q.Wu,
P.Datta,
E.S.Alnemri,
Y.Shi,
and
P.Dataa
(2001).
Structural basis of caspase-7 inhibition by XIAP.
|
| |
Cell, 104,
769-780.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Chai,
Q.Wu,
E.Shiozaki,
S.M.Srinivasula,
E.S.Alnemri,
and
Y.Shi
(2001).
Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding.
|
| |
Cell, 107,
399-407.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Rotonda,
M.Garcia-Calvo,
H.G.Bull,
W.M.Geissler,
B.M.McKeever,
C.A.Willoughby,
N.A.Thornberry,
and
J.W.Becker
(2001).
The three-dimensional structure of human granzyme B compared to caspase-3, key mediators of cell death with cleavage specificity for aspartic acid in P1.
|
| |
Chem Biol, 8,
357-368.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.J.Riedl,
M.Renatus,
R.Schwarzenbacher,
Q.Zhou,
C.Sun,
S.W.Fesik,
R.C.Liddington,
and
G.S.Salvesen
(2001).
Structural basis for the inhibition of caspase-3 by XIAP.
|
| |
Cell, 104,
791-800.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.J.Riedl,
P.Fuentes-Prior,
M.Renatus,
N.Kairies,
S.Krapp,
R.Huber,
G.S.Salvesen,
and
W.Bode
(2001).
Structural basis for the activation of human procaspase-7.
|
| |
Proc Natl Acad Sci U S A, 98,
14790-14795.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
U.Sartorius,
I.Schmitz,
and
P.H.Krammer
(2001).
Molecular mechanisms of death-receptor-mediated apoptosis.
|
| |
Chembiochem, 2,
20-29.
|
 |
|
|
|
|
 |
Y.Huang,
Y.C.Park,
R.L.Rich,
D.Segal,
D.G.Myszka,
and
H.Wu
(2001).
Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain.
|
| |
Cell, 104,
781-790.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Y.Jones
(2000).
The tumour necrosis factor receptor family: life or death choices.
|
| |
Curr Opin Struct Biol, 10,
644-648.
|
 |
|
|
|
|
 |
J.C.Reed,
and
K.J.Tomaselli
(2000).
Drug discovery opportunities from apoptosis research.
|
| |
Curr Opin Biotechnol, 11,
586-592.
|
 |
|
|
|
|
 |
M.G.Grütter
(2000).
Caspases: key players in programmed cell death.
|
| |
Curr Opin Struct Biol, 10,
649-655.
|
 |
|
|
|
|
 |
M.Renatus,
Q.Zhou,
H.R.Stennicke,
S.J.Snipas,
D.Turk,
L.A.Bankston,
R.C.Liddington,
and
G.S.Salvesen
(2000).
Crystal structure of the apoptotic suppressor CrmA in its cleaved form.
|
| |
Structure, 8,
789-797.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.W.Fesik
(2000).
Insights into programmed cell death through structural biology.
|
| |
Cell, 103,
273-282.
|
 |
|
|
|
|
 |
Y.Wei,
T.Fox,
S.P.Chambers,
J.Sintchak,
J.T.Coll,
J.M.Golec,
L.Swenson,
K.P.Wilson,
and
P.S.Charifson
(2000).
The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity.
|
| |
Chem Biol, 7,
423-432.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.S.Salvesen
(1999).
Caspase 8: igniting the death machine.
|
| |
Structure, 7,
R225-R229.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|